Tumour Organoid Drug Sensitivity Test
Model: Patient-Derived Organoids (PDO)
Category: Precision Medicine
Exhibitor: BIOMORGAN LIMITED
Booth No: N1108
Characteristic
An in‑vitro laboratory assessment that evaluates how patient‑derived tumour organoids respond to different therapeutic options. The test provides clinicians with additional scientific insights that may be considered alongside other clinical inputs.
Other Products
Products you may be interested in
Highest Rated Products